Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · see citing works
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · see citing works
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617 · see citing works
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498 · see citing works
(1989) · PubMed · Cited by 3,343 · see citing works
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · see citing works
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158 · see citing works
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,870 · see citing works
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822 · see citing works
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727 · see citing works
Self-citationThe unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,498 · see citing works
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,319 · see citing works
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213 · see citing works
(1996) · PubMed · Cited by 1,188 · see citing works
Respiratory physiology: The essentials
(1975) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(75)90100-x · Cited by 1,120 · see citing works
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106 · see citing works
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., & Dewhirst, M. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00101-6 · Cited by 1,068 · see citing works
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952 · see citing works
Self-citationNordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942 · see citing works
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., HAVEMAN, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 904 · see citing works
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 817 · see citing works
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Bauβnann, E., Mitze, M., Knapstein, P. G., & Vaupel, P. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90025-4 · Cited by 809 · see citing works
Self-citationGatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., & Broder, G. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90002-8 · Cited by 798 · see citing works
Oxidative Phosphorylation and Photophosphorylation
Boyer, P. D., Chance, B., Ernster, L., Mitchell, P. D., Racker, E., & Slater, E. C. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004515 · Cited by 750 · see citing works
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D. M., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R. M., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739 · see citing works
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcon, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660 · see citing works
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 651 · see citing works
Graeber, T. G., Peterson, J., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 613 · see citing works
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611 · see citing works
Oxygenation predicts radiation response and survival in patients with cervix cancer
Fyles, A., Milosevic, M., Wong, R. K. W., Kavanagh, M.-C., Pintilie, M., Sun, A. Y., Chapman, W. C., Levin, W., Manchul, L., Keane, T. J., et al. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00044-9 · Cited by 597 · see citing works
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562 · see citing works
Teicher, B. A., Lazo, J. S., & Sartorelli, A. C. (1981) · PubMed · Cited by 555 · see citing works
Heat Shock Proteins Increase Resistance to Apoptosis
Samali, A., & Cotter, T. G. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0070 · Cited by 522 · see citing works
Tannock, I. F., Hill, R. P., & Carey, R. W. (1989) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198905000-00037 · Cited by 473 · see citing works
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., et al. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463 · see citing works
Koong, A. C., Chen, E. Y., & Giaccia, A. J. (1994) · PubMed · Cited by 444 · see citing works
23 Genetic instability induced by the tumor microenvironment
Glazer, P. M., Reynolds, T. Y., & Rockwell, S. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)80581-0 · Cited by 427 · see citing works
Tumor hypoxia: its impact on cancer therapy
Moulder, J. E., & Rockwell, S. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00055376 · Cited by 413 · see citing works
Wilson, D. F., Rumsey, W. L., Green, T. J., & Vanderkooi, J. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69126-4 · Cited by 387 · see citing works
Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
Young, S. D., Marshall, R. S., & Hill, R. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9533 · Cited by 381 · see citing works
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 380 · see citing works
Sevick, E., Chance, B., Leigh, J. S., Nioka, S., & Maris, M. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90339-u · Cited by 360 · see citing works
Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements.
Höckel, M., Schlenger, K., Knoop, C., & Vaupel, P. W. (1991) · PubMed · Cited by 350 · see citing works
Self-citationVaria, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., & Raleigh, J. A. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5163 · Cited by 342 · see citing works
Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson, B. W., & Fingar, V. H. (1987) · PubMed · Cited by 339 · see citing works
Microenvironment-induced cancer metastasis
Rofstad, E. K. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138259 · Cited by 330 · see citing works
Hypoxic cervical cancers with low apoptotic index are highly aggressive.
Höckel, M., Schlenger, K., Höckel, S., & Vaupel, P. W. (1999) · PubMed · Cited by 327 · see citing works
Self-citationStone, H. B., Brown, J. M., Phillips, T. L., & Sutherland, R. M. (1993) · Radiation Research · doi:10.2307/3578556 · Cited by 303 · see citing works
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288 · see citing works
Hypoxia and radiation response in human tumors
Höckel, M., Schlenger, K., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80031-2 · Cited by 277 · see citing works
Self-citationHypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
Dachs, G. U., & Tozer, G. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00159-3 · Cited by 272 · see citing works
Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.
Kallinowski, F., Schlenger, K., Runkel, S., Kloes, M., Stohrer, M., Okunieff, P., & Vaupel, P. W. (1989) · PubMed · Cited by 269 · see citing works
Self-citationRice, G. C., Hoy, C., & Schimke, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5978 · Cited by 254 · see citing works
Tumor tissue oxygenation as evaluated by computerized-po2-histography
Kallinowski, F., Zander, R., Hoeckel, M., & Vaupel, P. W. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90018-f · Cited by 253 · see citing works
Self-citationOxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells.
Moan, J. E., & Sommer, S. (1985) · PubMed · Cited by 225 · see citing works
Teicher, B. A., Holden, S. A., Al-Achi, A., & Herman, T. S. (1990) · PubMed · Cited by 225 · see citing works
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Valk, P. E., Mathis, C. A., Prados, M. D., Gilbert, J. C., & Budinger, T. F. (1992) · PubMed · Cited by 224 · see citing works
Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
Lord, E. M., Harwell, L. W., & Koch, C. J. (1993) · PubMed · Cited by 223 · see citing works
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
Anthoney, A., McIlwrath, A. J., Gallagher, W. M., Edlin, A., & Brown, R. E. (1996) · PubMed · Cited by 210 · see citing works
Knocke, T.-H., Weitmann, H.-D., Feldmann, H.-J., Selzer, E., & Pötter, R. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00139-5 · Cited by 210 · see citing works
Gross, M. W., Karbach, U., Groebe, K., Franko, A. J., & Mueller‐Klieser, W. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610422 · Cited by 206 · see citing works
Oxymetry deep in tissues with low-frequency electron paramagnetic resonance.
Halpern, H. J., Cai-li, Y., Perić, M., Barth, E. D., Grdina, D. J., & Teicher, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.13047 · Cited by 195 · see citing works
Kennedy, A. S., Raleigh, J. A., Perez, G. M., Calkins, D. P., Thrall, D. Ε., Novotny, D. B., & Varia, M. A. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00539-1 · Cited by 192 · see citing works
Basic Principles of Tissue Oxygen Determination from Mitochondrial Signals
Chance, B., Oshino, N., Sugano, T., & Mayevsky, A. (1973) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-3288-6_35 · Cited by 191 · see citing works
Sundfør, K., Lyng, H., & Rofstad, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.586 · Cited by 187 · see citing works
The OxyLite: a fibre-optic oxygen sensor.
Griffiths, J. R., & Robinson, S. P. (1999) · British Journal of Radiology · doi:10.1259/bjr.72.859.10624317 · Cited by 186 · see citing works
Vaupel, P. W., Fortmeyer, H. P., Runkel, S., & Kallinowski, F. (1987) · PubMed · Cited by 181 · see citing works
Self-citationKoch, C., Evans, S. M., & Lord, E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.426 · Cited by 178 · see citing works
Genomic Instability and Tumor Progression: Mechanistic Considerations
Cheng, K. C., & Loeb, L. A. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60824-6 · Cited by 174 · see citing works
Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy
Democheli, R., Tereziani, M., Valagussa, P., Moliterni, A., Zambetti, M., & Bonadonna, G. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.1.45 · Cited by 174 · see citing works
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
Chapman, J. D., Engelhardt, E. L., Stobbe, C. C., Schneider, R. F., & Hanks, G. E. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00186-2 · Cited by 164 · see citing works
Hypoxia-induced up-regulation of angiogenin in human malignant melanoma.
Hartmann, A., Kunz, M., Köstlin, S., Gillitzer, R., Toksoy, A., Bröcker, E. B., & Klein, C. E. (1999) · PubMed · Cited by 160 · see citing works
Parliament, M. B., Chapman, J., Urtasun, R. C., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.17 · Cited by 158 · see citing works
Cuvier, C., Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018428105463 · Cited by 156 · see citing works
Hypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 155 · see citing works
Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
Urtasun, R. C., Chapman, J. D., Raleigh, J. A., et al. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90273-7 · Cited by 149 · see citing works
Tumor Radiosensitivity and Apoptosis
Zhivotovsky, B., Joseph, B., & Orrenius, S. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4452 · Cited by 148 · see citing works
The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas
Nordsmark, M., Høyer, M., Keller, J. O., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(96)00132-0 · Cited by 145 · see citing works
Kim, C., Tsai, M. H., Osmanian, C., Graeber, T. G., Lee, J. E., Giffard, R. G., DiPaolo, J. A., Peehl, D. M., & Giaccia, A. J. (1997) · PubMed · Cited by 143 · see citing works
The inhibition of tumor growth by tumor mass.
Prehn, R. T. (1991) · PubMed · Cited by 136 · see citing works
Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells.
Mitchell, J. B., McPherson, S., DeGraff, W., Gamson, J., Zabell, A., & Russo, A. (1985) · PubMed · Cited by 136 · see citing works
Intracapillary oxyhemoglobin saturation of malignant tumors in humans
Mueller‐Klieser, W., Vaupel, P. W., Manz, R., et al. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90036-5 · Cited by 129 · see citing works
Self-citationChapman, J. D. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90181-f · Cited by 128 · see citing works
Blood Perfusion and Microenvironment of Human Tumors
(2000) · Medical radiology · doi:10.1007/978-3-642-58813-6 · Cited by 126 · see citing works
Imaging tumor hypoxia and tumor perfusion.
Groshar, D., McEwan, A. J. B., Parliament, M. B., et al. (1993) · PubMed · Cited by 122 · see citing works
Tumor radiosensitivity and apoptosis
Guang, Z. (2000) · Cited by 121 · see citing works
Tumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy
Sutherland, R. M. (1998) · Acta Oncologica · doi:10.1080/028418698430278 · Cited by 119 · see citing works
Early Wound Healing Exhibits Cytokine Surge Without Evidence of Hypoxia
Haroon, Z. A., Raleigh, J. A., Greenberg, C. S., & Dewhirst, M. W. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00020 · Cited by 117 · see citing works
Tumour Hypoxia: The Picture Has Changed in the 1990s
Brown, J., & Giaccia, A. J. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414550131 · Cited by 114 · see citing works
Regulation of c- jun Expression during Hypoxic and Low-Glucose Stress
Ausserer, W. A., Bourrat-Floeck, B., Green, C. J., Laderoute, K. R., & Sutherland, R. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5032-5042.1994 · Cited by 114 · see citing works
The influence of microenvironmental factors during cancer therapy.
Durand, R. E. (1995) · PubMed · Cited by 112 · see citing works
Apoptosis and cancer chemotherapy
Hickman, J. A., Potten, C. S., Merritt, A. J., & Fisher, T. C. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0112 · Cited by 110 · see citing works
Raleigh, J. A., Dewhirst, M. W., & Thrall, D. Ε. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80034-8 · Cited by 109 · see citing works
Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance
Sakata, K., Kwok, T. T., Murphy, B. J., Laderoute, K. R., Gordon, G. R., & Sutherland, R. J. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.405 · Cited by 104 · see citing works
Non-invasive determination of tumor oxygen tension and local variation with growth
Mason, R. P., Antich, P. P., Babcock, E. E., Constantinescu, A., Peschke, P., & Hahn, E. W. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90231-3 · Cited by 104 · see citing works
Sundfør, K., Lyng, H., Tropé, C., & Rofstad, E. K. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00175-9 · Cited by 103 · see citing works
The effect of hypoxia on the growth and radiation response of mammalian cells in culture
Bedford, J. S., & Mitchell, J. B. (1974) · British Journal of Radiology · doi:10.1259/0007-1285-47-562-687 · Cited by 101 · see citing works
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans, S. M., Jenkins, W. T., Joiner, B., Lord, E. M., & Koch, C. J. (1996) · PubMed · Cited by 98 · see citing works
In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives
Rudin, M., Beckmann, N., Pórszász, R., Reese, T., Bochelen, D., & Sauter, A. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199904)12:2 · Cited by 98 · see citing works
Oxygen Dependency of Tumor Cell Killing in Vitro by Light-Activated Photofrin II
Chapman, J. D., Stobbe, C. C., Arnfield, M. R., et al. (1991) · Radiation Research · doi:10.2307/3578173 · Cited by 98 · see citing works
Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging.
Wilson, D. F., & Cerniglia, G. J. (1992) · PubMed · Cited by 92 · see citing works
Collingridge, D. R., Young, W. K., Vojnovic, B., Wardman, P., Lynch, E. M., Hill, S. A., & Chaplin, D. J. (1997) · Radiation Research · doi:10.2307/3579340 · Cited by 87 · see citing works
Blood perfusion and microenvironment of human tumors : implications for clinical radiooncology
Molls, M., & Vaupel, P. W. (1998) · Cited by 86 · see citing works
Self-citationThe respiration of ascites tumour cells at low oxygen concentrations
Froese, G. (1962) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(62)91158-7 · Cited by 86 · see citing works
Hypoxia‐induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro
Sanna, K., & Rofstad, E. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580219 · Cited by 85 · see citing works
Keynote address: The influence of microenvironmental factors on the activity of radiation and drugs
Durand, R. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90100-i · Cited by 83 · see citing works
Oxygen diffusion and mitochondrial respiration in neuroblastoma cells
Robiolio, M., Rumsey, W. L., & Wilson, D. F. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.6.c1207 · Cited by 80 · see citing works
Russo, C. A., Weber, T. K., Volpe, C. M., et al. (1995) · PubMed · Cited by 76 · see citing works
Drug Resistance in Chinese Hamster Ovary Cells During Recovery From Severe Hypoxia
Wilson, R. E., Keng, P. C., & Sutherland, R. M. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.16.1235 · Cited by 74 · see citing works
Hasan, N. M., Adams, G., Joiner, M. C., Marshall, J. F., & Hart, I. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.299 · Cited by 68 · see citing works
Wendling, P. W. C., Manz, R., Thews, G., & Vaupel, P. W. (1984) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4895-5_28 · Cited by 68 · see citing works
Self-citationCarbogen-induced changes in rat mammary tumour oxygenation reported by near infrared spectroscopy
Hull, E. L., Conover, D. L., & Foster, T. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690272 · Cited by 68 · see citing works
Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018470709523 · Cited by 67 · see citing works
Overexpression and mutations of p53 in metastatic malignant melanomas
Hartmann, A., Blaszyk, H., Cunningham, J. S., McGovern, R. M., Jj, S., Helander, S. D., Pittelkow, M. R., Sommer, S. S., & Kovach, J. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3 · Cited by 63 · see citing works
Fishman, J. E., Joseph, P. M., Carvlin, M. J., et al. (1989) · Investigative Radiology · doi:10.1097/00004424-198901000-00014 · Cited by 61 · see citing works
Azuma, C., Raleigh, J. A., & Thrall, D. Ε. (1997) · Radiation Research · doi:10.2307/3579536 · Cited by 61 · see citing works
Physiological properties of malignant tumours
Vaupel, P. W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050505 · Cited by 58 · see citing works
Self-citationRegional Tumor Oximetry: 19F NMR Spectroscopy of Hexafluorobenzene
Hunjan, S., Mason, R. P., CONSTANTINESCU, A., et al. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00020-0 · Cited by 58 · see citing works
Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours
Cline, J. M., Thrall, D. Ε., Page, R. L., et al. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.411 · Cited by 58 · see citing works
Rofstad, E., Fenton, B., & Sutherland, R. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.113 · Cited by 55 · see citing works
Metabolic Status and Reaction to Heat of Normal and Tumor Tissue
Vaupel, P. W., & Kelleher, D. K. (1995) · Medical radiology · doi:10.1007/978-3-642-57858-8_8 · Cited by 53 · see citing works
Self-citationvan der Sanden, B. P. J., Heerschap, A., Simonetti, A. W., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00555-0 · Cited by 53 · see citing works
Vaupel, P. W., Schaefer, C. A., & Okunieff, P. G. (1994) · NMR in Biomedicine · doi:10.1002/nbm.1940070305 · Cited by 50 · see citing works
Self-citationStoler, D. L., Anderson, G. R., Russo, C. A., et al. (1992) · PubMed · Cited by 50 · see citing works
The Effect of Hypoxia on the Generation Time of Mammalian Cells
Koch, C. J., Kruuv, J., & Frey, H. E. (1973) · Radiation Research · doi:10.2307/3573446 · Cited by 49 · see citing works
Distribution of the hypoxia marker CCI-103F in canine tumors
Cline, J. M., Thrall, D. Ε., Rosner, G. L., et al. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90113-9 · Cited by 49 · see citing works
Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene
Le, D., Mason, R. P., Hunjan, S., et al. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(97)00035-0 · Cited by 49 · see citing works
Cellular physiology and molecular events in hypoxia-induced apoptosis.
Riva, C., Chauvin, C., Pison, C. M., & Leverve, X. M. (1998) · PubMed · Cited by 49 · see citing works
Modern cardiovascular physiology
Honig, C. R. (1981) · Medical Entomology and Zoology · Cited by 46 · see citing works
Chiarotto, J. A., & Hill, R. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690555 · Cited by 46 · see citing works
Glossary on respiration and gas exchange.
(1973) · Journal of Applied Physiology · doi:10.1152/jappl.1973.34.4.549 · Cited by 46 · see citing works
Fenton, B. M., Rofstad, E. K., Degner, F. L., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.20.1612 · Cited by 46 · see citing works
Åmellem, Ø., Löffler, M., & Pettersen, E. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.411 · Cited by 44 · see citing works
Laderoute, K. R., Grant, T. D., Murphy, B. J., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520317 · Cited by 42 · see citing works
Benign-to-Malignant B16 melanoma Progression Induced in Two Stages In Vitro by Exposure to Hypoxi
Stackpole, C. W., Groszek, L., & Kalbag, S. S. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.361 · Cited by 40 · see citing works
Freitas, I., & Baronzio, G. F. (1991) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/1011-1344(91)80264-i · Cited by 40 · see citing works
Pettersen, E. O., & Lindmo, T. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.271 · Cited by 39 · see citing works
Pathophysiological approaches to identifying tumor hypoxia in patients
Mueller-Klieser, W., Schlenger, K., Walenta, S., et al. (1991) · Radiotherapy and Oncology · doi:10.1016/0167-8140(91)90182-g · Cited by 38 · see citing works
Self-citationChapman, J. D., McPhee, M. S., Walz, N., CHETNER, M. P., Stobbe, C. C., Soderlind, K. J., Arnfield, M. R., Meeker, B. E., Trimble, L. A., & Allen, P. S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.22.1650 · Cited by 38 · see citing works
Microvasculature and Perfusion in Normal Tissues and Tumors
Song, C. W., Choi, I.-B., Nah, B. S., et al. (1995) · Medical radiology · doi:10.1007/978-3-642-57858-8_7 · Cited by 37 · see citing works
Proposal for Using a Standardized Terminology on Oxygen Transport to Tissue
Zander, R., & Vaupel, P. W. (1985) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-3291-6_98 · Cited by 33 · see citing works
Self-citationKrüger, W., Mayer, W. K., Schaefer, C. A., et al. (1991) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01612759 · Cited by 32 · see citing works
Self-citationMeasurements of pO2 in Vivo, Including Human Subjects, by Electron Paramagnetic Resonance
Swartz, H. M., Bačić, G., Friedman, B. J., et al. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1875-4_16 · Cited by 31 · see citing works
Marshall, R. S., Koch, C. J., & Rauth, A. M. (1986) · Radiation Research · doi:10.2307/3576973 · Cited by 28 · see citing works
Pfosser, A., Brandl, M., Salih, H., Große‐Hovest, L., & Jung, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4 · Cited by 27 · see citing works
Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.
McCoy, C. L., McIntyre, D. J. O., Robinson, S. P., et al. (1996) · PubMed · Cited by 26 · see citing works
Allelotype analysis of early colorectal cancers with lymph node metastasis
Arai, T., Akiyama, Y., Yamamura, A., Hosoi, T., Shibata, T., Saitoh, K., Okabe, S., & Yuasa, Y. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4 · Cited by 26 · see citing works
Self-citationSeiden, M. V., Ng, S., Supko, J. G., et al. (2002) · PubMed · Cited by 26 · see citing works
Starlinger, H., L�bbers, D. W., Dannappel, D., et al. (1972) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00587868 · Cited by 25 · see citing works
The Influence of Variable Oxygen Concentration on the Response of Cells to Heat or X Irradiation
Gerweck, L. E., Richards, B., & Jennings, M. (1981) · Radiation Research · doi:10.2307/3575564 · Cited by 23 · see citing works
Therapeutic Significance of Microenvironmental Factors
Chaplin, D. J., Horsman, M. R., Trotter, M. J., & Siemann, D. W. (2000) · Medical radiology · doi:10.1007/978-3-642-58813-6_13 · Cited by 22 · see citing works
Energy Status and Radiobiological Hypoxia at Specified Oxygen Concentrations
Gerweck, L. E., Seneviratne, T., & Gerweck, K. K. (1993) · Radiation Research · doi:10.2307/3578398 · Cited by 21 · see citing works
Raleigh, J. A. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80030-0 · Cited by 11 · see citing works
Monitoring cancer by magnetic resonance.
Stubbs, M., & Griffiths, J. R. (1999) · PubMed · Cited by 9 · see citing works
Measurement of Hypoxia in Vivo Using A 2-Nitromidazole (NITP)
Hodgkiss, R. J., Webster, L., & Wilson, G. D. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5399-1_10 · Cited by 8 · see citing works
Oxygenation and Bioenergetic Status of Murine Fibrosarcomas
Schaefer, C. A., Okunieff, P. G., & Vaupel, P. W. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-3428-0_16 · Cited by 3 · see citing works
Self-citationRonai, Z. A., Polotskaya, A., Gradia, S., Amin, S. G., & Hecht, S. S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960703)67:1 · Cited by 2 · see citing works
Misonidazole Labeling as a Marker of Cellular Hypoxia
Parliament, M. B., & Urtasun, R. C. (2000) · Medical radiology · doi:10.1007/978-3-642-58813-6_9 · Cited by 2 · see citing works
Flagged first, then by citations
1 of the 159 references couldn’t be matched to a known paper.
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works
“A large body of data has indicated that hypoxic cancer cells are more likely to be resistant to radiation and chemotherapy, and have increased potential for invasion, metastasis and patient mortalit”
BackgroundOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441 · see citing works
“tumors is associated with increased metastasis and poor survival of patients with several forms of squamous tumor [232,233].”
BackgroundHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works
“Direct evidence of hypoxia in human cancers has been shown most convincingly by the pioneering work of Peter Vaupel and colleagues, who studied the tumour oxygen supply using oxygen electrode”
BackgroundReactive oxygen species in cancer
Liou, G., & Störz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,394 · see citing works
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240 · see citing works
Self-citationHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · see citing works
“Such a supply-demand mismatch can occur in physiologic conditions such as the exercising muscle, in the pathologic condition such as the ischemic heart, or in the tumor microenvironment (Hockel and Vaupel, 2001; Semenza, 2004).”
BackgroundReactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. S. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,104 · see citing works
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707 · see citing works
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
BackgroundBingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022 · see citing works
“The presence of multiple areas of hypoxia (pathologically low oxygen tension) is a hallmark feature of many types of human tumour [98].”
BackgroundNormalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605 · see citing works
Lü, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,432 · see citing works
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309 · see citing works
RetractedTumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,230 · see citing works
“Several chemotherapeutic drugs are also less active in the acidic microenvironment associated with hypoxia (reviewed in Hockel and Vaupel, 2001; Minchinton and Tannock, 2006).”
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231 · see citing works
“Increased metastases, enhanced tumor progression, and decreased patient survival have been associated with primary tumors that contain large numbers of poorly oxygenated (hypoxic) tumor cells (Cairns et al., 2003; Hockel and Vaupel, 2001; Pouyssegur et al., 2006).”
BackgroundDiffuse optics for tissue monitoring and tomography
Durduran, T., Choe, R., Baker, W. B., & Yodh, A. G. (2010) · Reports on Progress in Physics · doi:10.1088/0034-4885/73/7/076701 · Cited by 1,168 · see citing works
“[351–353].”
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311 · see citing works
A dual-emissive-materials design concept enables tumour hypoxia imaging
Zhang, G., Palmer, G. M., Dewhirst, M. W., & Fraser, C. L. (2009) · Nature Materials · doi:10.1038/nmat2509 · Cited by 1,151 · see citing works
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060 · see citing works
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050 · see citing works
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
van Straten, D., Mashayekhi, V., de Bruijn, H., Oliveira, S., & Robinson, D. J. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,023 · see citing works
“These low oxygen areas are already present pre-PDT [316] or emerge due to PDT oxygen consumption or vascular collapse [54].”
BackgroundReactive oxygen species in tumor progression
Peter, S. F. (2005) · Frontiers in bioscience · doi:10.2741/1667 · Cited by 957 · see citing works
“This adaptation of tumor cells to hypoxia contributes to the malignant phenotype and to aggressive tumor progression (27), and low oxygen tension in tumors is associated with increased metastasis and poor survival of patients in several squamous tumors (28, 29).”
BackgroundRaval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
“Associations between microenvironmental hypoxia, activation of hypoxia pathways, and aggressively malignant phenotypes are observed across a range of cancers, focusing attention on molecular dissection of these pathways and how they contribute to tumor biology (8, 9).”
BackgroundTumor microenvironmental physiology and its implications for radiation oncology
Vaupel, P. W. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.008 · Cited by 948 · see citing works
Self-citationCheng, Y., Cheng, H., Jiang, C., Qiu, X., Wang, K., Huan, W., Yuan, A., Wu, J., & Hu, Y. (2015) · Nature Communications · doi:10.1038/ncomms9785 · Cited by 941 · see citing works
Rozpędek‐Kamińska, W., Pytel, D., Mucha, B., Leszczynska, H., Diehl, J. A., & Majsterek, I. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160523143937 · Cited by 871 · see citing works
“The uncontrolled growth of tumor cells forming an enlarging mass causes the distance between existing blood vessels to increase and creates areas of acute and chronic hypoxia [27].”
BackgroundLu, H., Forbes, R. A., & Verma, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 832 · see citing works
The Role of Hypoxia-Induced Factors in Tumor Progression
Vaupel, P. W. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-10 · Cited by 831 · see citing works
“It has also been suggested that hypoxia exerts a strong selection pressure on malignant cells [5, 6 , 51, 52].”
BackgroundInfluentialSelf-citationThe role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768 · see citing works
Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response
Vaupel, P., & Harrison, L. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-4 · Cited by 761 · see citing works
“Evidence from recent studies suggests that sustained (>6-8 hours) or fluctuating hypoxic stress (pO2 ≤7 mmHg) can lead to alterations (stimulation or inhibition) of gene expression, as well as posttranscriptional and posttranslational modulations that result in changes in the tumor cell proteome (Fig. 6) [ 9-11 , 16].”
BackgroundInfluentialSelf-citationShining carbon dots: Synthesis and biomedical and optoelectronic applications
Yuan, F., Li, S., Fan, Z., Meng, X., Fan, L., & Yang, S. (2016) · Nano Today · doi:10.1016/j.nantod.2016.08.006 · Cited by 750 · see citing works
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721 · see citing works
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735 · see citing works
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Bi, M., Naczki, C., Koritzinsky, M., Fels, D. R., Blais, J. D., Hu, N., Harding, H. P., Novoa, I., Varia, M. A., Raleigh, J. A., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600777 · Cited by 732 · see citing works
“The development of fluctuating hypoxic and anoxic regions in tumors has profound consequences for malignant progres- sion, response to therapy and overall patient survival (Hockel and Vaupel, 2001).”
BackgroundDetection and Characterization of Tumor Hypoxia Using pO <sub>2</sub> Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728 · see citing works
“In this discussion of hypoxic thresholds, it is important to note that, for any particular functional parameter, a sharp threshold between “hy-poxia” ( i.e. , more hypoxic tumors) and “normoxia” ( i.e. , less hypoxic tumors) does not exist and should not be expected (51).”
InfluentialSelf-citationDelivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718 · see citing works
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687 · see citing works
“%) is estimated to represent a critical PO2 since lower PO2 values are associated with adverse effects caused by reduced O2 consumption (Hockel & Vaupel, 2001).”
BackgroundPastoreková, S., Parkkila, S., Pastorek, J., & Supuran, C. T. (2004) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360410001689540 · Cited by 662 · see citing works
Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance
Mallidi, S., Luke, G. P., & Emelianov, S. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.01.006 · Cited by 646 · see citing works
“Hypoxia is often linked to malignancy and resistance to therapy [32].”
BackgroundTargeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 637 · see citing works
“tween tumor cell proliferation, which is faster than the rate of blood vessel formation, thereby leading to a compromised tumor blood supply [217].”
BackgroundTatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620 · see citing works
“There appears to be a vicious circle (Hockel & Vaupel 2001a, Hockel & Vaupel 2001b) in which hypoxia-induced changes promote malignant progression and increased aggressiveness, leading to tumor propagation and further tumor hypoxia.”
BackgroundImaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614 · see citing works
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608 · see citing works
Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584 · see citing works
“Tumor hypoxia correlated with poor outcome even when surgery was the only treatment and is now considered as a prognostic factor for overall tumor aggressiveness and resistance to therapy [Hockel and Vaupel, 2001].”
BackgroundGraham, K., & Unger, E. C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s140462 · Cited by 581 · see citing works
“tissue.(15) Profound hypoxia promotes changes in the proteome and genome.”
BackgroundTreatment Resistance of Solid Tumors
Vaupel, P. W., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 557 · see citing works
“Other consequences of hypoxia-induced malignant progression are an increased locoregional spread and enhanced metastasis ( 4 ,87).”
BackgroundInfluentialSelf-citationTumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
Shannon, A. M., Bouchier-Hayes, D. J., Condron, C. M., & Toomey, D. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00003-3 · Cited by 559 · see citing works
Nonlinear modelling of cancer: bridging the gap between cells and tumours
Lowengrub, J. S., Frieboes, H. B., Jin, F., Chuang, Y.-L., Li, X., Macklin, P., Wise, S. M., & Vittorio Cristini, C. (2009) · Nonlinearity · doi:10.1088/0951-7715/23/1/r01 · Cited by 549 · see citing works
“It is also supposed that the pressure jump across the necrotic interface is zero, which reflects the low cell–cell adhesion in the perinecrotic region and the increased cellular mobility observed in hypoxic cells [75,99,265,423,424,454].”
Navigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 556 · see citing works
Role of iron in carcinogenesis: cancer as a ferrotoxic disease
Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552 · see citing works
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539 · see citing works
“after the onset of angiogenesis, O2 delivery may remain inadequate because the vasculature is often abnormal and heterogeneous [35].”
BackgroundTargeted photoredox catalysis in cancer cells
Huang, H., Banerjee, S., Qiu, K., Zhang, P., Blacque, O., Malcomson, T., Paterson, M. J., Clarkson, G. J., Staniforth, M. J., Stavros, V. G., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0328-4 · Cited by 545 · see citing works
Cancer stem cell niche: the place to be
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3220 · Cited by 518 · see citing works
“byproduct of radiotherapy, would normally induce DNA damage in tumor cells (20).”
BackgroundSkeletal PET with 18 F-Fluoride: Applying New Technology to an Old Tracer
Grant, F. D., Fahey, F. H., Packard, A. B., Davis, R. T., Alavi, A. A., & Treves, S. T. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037200 · Cited by 519 · see citing works
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 518 · see citing works
“However, in the course of tumorigenesis, tumour expansion is constrained by alterations in its microenvironment, typically caused by the inadequacy of the local vasculature to supply sufficient oxygen and nutrients to the rapidly growing tumour, resulting in hypoxi”
BackgroundTumor hypoxia and malignant progression
Vaupel, P., Mayer, A., & Höckel, M. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)81023-1 · Cited by 496 · see citing works
Self-citationBos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500 · see citing works
Role of hypoxia in the hallmarks of human cancer
Ruan, K., Song, G., & Ouyang, G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22214 · Cited by 485 · see citing works
“The frequency of point mutations in tumorigenic cells cultured under severe hypoxic treatment is 3.4-fold higher than that observed in normally oxygenated cells [Hockel and Vaupel, 2001].”
BackgroundInfluentialOxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy
Vaupel, P. W., Kelleher, D. K., & ]ckel, M. H. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90210-6 · Cited by 481 · see citing works
Self-citationYC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E., Chun, Y., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 477 · see citing works
The emerging role of photoacoustic imaging in clinical oncology
Lin, L., & Wang, L. V. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00615-3 · Cited by 484 · see citing works
Li, W., Zhou, C., Yu, L., Hou, Z., Liu, H., Kong, L.-H., Xu, Y., He, J., Jin, L., Ou, Q., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2249762 · Cited by 486 · see citing works
Cancer as a robust system: implications for anticancer therapy
Kitano, H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1300 · Cited by 456 · see citing works
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aaf26a · Cited by 444 · see citing works
Src signaling in cancer invasion
Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 427 · see citing works
“Furthermore, hypoxia—a common characteristic of the tumor microenvironment (Höckel and Vaupel, 2001; Pennacchietti et al., 2003), can favor invasive growth and malignant progression by stimulating the Src/STAT3/VEGF pathway which then promotes angiogenesis, a step necessary for the growth of both…”
BackgroundSTAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H. S., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, S. E., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425 · see citing works
Walsh, J. C., Lebedev, A. Y., Aten, E., Madsen, K. S., Marciano, L., & Kolb, H. C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 419 · see citing works
“This survival mechanism is common among hypoxic tumors, resulting in a twofold increase in glucose uptake (determined in vitro) (29), elevated tissue acidity (44), and an evolutionary selection for a progressively more malignant phenotype (102, 122).”
Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents
Luke, G. P., Yeager, D., & Emelianov, S. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0449-4 · Cited by 418 · see citing works
Jin, C. S., Lovell, J. F., Chen, J., & Zheng, G. (2013) · ACS Nano · doi:10.1021/nn3058642 · Cited by 414 · see citing works
“tentiate tumor hypoxia, impeding therapeutic outcomes.(10,12,18,19) Thus, an oxygen-indepen-”
Cao, X., Ding, L., Xie, Z., Yang, Y., Whiteman, M., Moore, P. K., & Bian, J. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7058 · Cited by 409 · see citing works
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Thiry, A., Dogné, J., Masereel, B., & Supuran, C. T. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.002 · Cited by 396 · see citing works
“In tumors, hypoxia stems from an inadequate supply of oxygen, which is primarily a pathophysiological consequence of structurally and functionally disturbed microcirculation and the deterioration of O2 diffusion processes [ 7 ].”
BackgroundInfluentialHypoxia and the Tumor Microenvironment
Li, Y., Zhao, L., & Li, X.-F. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211036304 · Cited by 397 · see citing works
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392 · see citing works
“On the other hand, traditional chemotherapeutic agents commonly used for breast cancer treatment such as cyclophosphamide, carboplatin, and doxorubicin often become ineffective due to chemoresistance, particularly under hypoxic condition ( 52 ).”
BackgroundAngiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386 · see citing works
Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Mo, R., & Gu, Z. (2015) · Materials Today · doi:10.1016/j.mattod.2015.11.025 · Cited by 382 · see citing works
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy
Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0858 · Cited by 433 · see citing works
Autophagy: a barrier or an adaptive response to cancer
Ogier‐Denis, É., & Codogno, P. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00004-0 · Cited by 365 · see citing works
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders, J. H. A. M., Wijffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., & van der Kogel, A. J. (2002) · PubMed · Cited by 357 · see citing works
Paul, C., Teng, S., & Saunders, P. T. K. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.071779 · Cited by 356 · see citing works
“This can be in response to inadequate blood flow into the tissue or reduced oxygen transport capacity [11].”
BackgroundLi, M.-L., Oh, J., Xie, X., et al. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2007.913515 · Cited by 352 · see citing works
“Imaging of the oxygenation status of tumors, especially hypoxia, is receiving more and more attention in assessing tumor growth, malignant progression, metastasis, and resistance to various therapiesV including radiotherapy and chemotherapy as well as photodynamic therapy [23]–[ 27 ].”
BackgroundTumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 353 · see citing works
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N. G., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 351 · see citing works
Zhang, S., Hosaka, M., Yoshihara, T., Negishi, K., Iida, Y., Tobita, S., & Takeuchi, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3948 · Cited by 351 · see citing works
Hypoxia and Anemia: Factors in Decreased Sensitivity to Radiation Therapy and Chemotherapy?
Harrison, L. B., & Blackwell, K. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-31 · Cited by 349 · see citing works
“As indicated in Figure 1 and Table 1, hypoxia may also substantially enhance radioresistance by inducing proteomic and genomic changes that lead to increases in the number of tumor cells with diminished apoptotic potential or increased proliferative and metastatic potential, or that lead to increases in the levels of…”
BackgroundResultInfluentialJan, S. L., Amy, C., Cazes, A., Monnot, C., Lamandé, N., Favier, J., Philippe, J., Sibony, M., Gasc, J., Corvol, P. L., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64285-x · Cited by 342 · see citing works
“7 Indeed, HIF-1 (cid:2) regulates many genes, including those for erythropoietin, vascular endothelial growth factor (VEGF), tyrosine hydroxylase, inducible NO synthase (iNOS), and angiopoietin-2.”
BackgroundAirley, R. E., & Mobasheri, A. (2007) · Chemotherapy · doi:10.1159/000104457 · Cited by 342 · see citing works
“For example, the active species of bleomycin depends upon the formation of a DNA-bleomycin-ferrous ion-dioxygen complex that is oxidized in the presence of molecular oxygen [ ,”
BackgroundSignalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 343 · see citing works
Is diabetic retinopathy an inflammatory disease?
Adamis, A. P. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.363 · Cited by 342 · see citing works
HIF-1 regulation: not so easy come, easy go
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.002 · Cited by 339 · see citing works
“The physiology of hypoxia Hypoxia is a state of reduced oxygen pressure below a critical threshold, which restricts the function of organs, tissues or cells [ 1 ].”
BackgroundDuan, C., Yu, M., Xu, J., Li, B.-Y., Zhao, Y. H., & Kankala, R. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114643 · Cited by 345 · see citing works
Whole-Body Diffusion-weighted MR Imaging in Cancer: Current Status and Research Directions
Padhani, A. R., Koh, D., & Collins, D. J. (2011) · Radiology · doi:10.1148/radiol.11110474 · Cited by 332 · see citing works
Park, J.-S., Kim, I.-K., Han, S., Park, I., Kim, C., Bae, J., Oh, S. J., Lee, S., Kim, J. H., Woo, D.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.018 · Cited by 327 · see citing works
“microenvironment is not only hypoxic and acidic but also is surrounded by high interstitial pressure, which acts as a pathologic barrier to drug delivery into tumors (Gatenby and Gillies, 2004; Hockel and Vaupel, 2001; Jain, 2005).”
BackgroundStimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332 · see citing works
Nanopreparations to overcome multidrug resistance in cancer
Patel, N. R., Pattni, B. S., Abouzeid, A. H., & Torchilin, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.004 · Cited by 334 · see citing works
“The pathogenesis of tumor hypoxia is well explained by Vaupel et al [74, 75].”
BackgroundMetabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, E. G., & Barbas, C. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 330 · see citing works
Imaging oxygenation of human tumours
Padhani, A. R., Krohn, K. A., Lewis, J. S., & Alber, M. L. (2006) · European Radiology · doi:10.1007/s00330-006-0431-y · Cited by 328 · see citing works
“With these caveats in mind, the critical pO2 tensions below which cellular functions progressively cease or anticancer treatments are impaired are approximately as follows [13]: Effectiveness of immunotherapy becomes impaired (30–35 mmHg); Photodynamic therapy (15–35 mmHg); Cell death on exposure to radiation (25– 30…”
BackgroundHyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy
Gong, H., Chao, Y., Xiang, J., Han, X., Song, G., Feng, L., Liu, J., Yang, G., Chen, Q., & Liu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00068 · Cited by 322 · see citing works
MRI-Guided Diffuse Optical Spectroscopy of Malignant and Benign Breast Lesions
Ntziachristos, V., Yodh, A. G., Schnall, M. D., & Chance, B. (2002) · Neoplasia · doi:10.1038/sj.neo.7900244 · Cited by 321 · see citing works
Karimi, M., Eslami, M., Sahandi‐Zangabad, P., Mirab, F., Farajisafiloo, N., Shafaei, Z., Ghosh, D., Bozorgomid, M., Dashkhaneh, F., & Hamblin, M. R. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1389 · Cited by 327 · see citing works
Three-dimensional context regulation of metastasis
Erler, J. T., & Weaver, V. M. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9209-8 · Cited by 314 · see citing works
The urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312 · see citing works
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review